Clinical Trials Directory

Trials / Terminated

TerminatedNCT03754452

Evaluation of the Sarcopenia in Hepatobiliary Surgery

Evaluation of the Prevalence, the Diagnosis Tests, and the Associated Morbimortality of Sarcopenia in Hepatobiliary Surgery

Status
Terminated
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The sarcopenia is defined as a loss of muscle mass and a loss of muscle function ( strength or performance). Some studies showed that the sarcopenia increase the postoperative complications and the overall survival in abdominal surgery. But the sarcopenia is not evaluated in the Hepatobiliary surgery. This prospective, monconcentrique study aim to evaluate the prevalence of sarcopenia, and its associated morbimortality in hepatobiliary surgery for malignant or benign tumors.

Conditions

Timeline

Start date
2018-11-09
Primary completion
2021-09-07
Completion
2021-09-07
First posted
2018-11-27
Last updated
2024-01-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03754452. Inclusion in this directory is not an endorsement.

Evaluation of the Sarcopenia in Hepatobiliary Surgery (NCT03754452) · Clinical Trials Directory